Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Other
Warfarin is a potent Vitamin K antagonist (VKA) anticoagulant used to prevent and treat thromboembolic disorders. It requires precise dosing and regular INR monitoring to manage the risk of significant bleeding.
Name
Warfarin
Raw Name
WARFARIN SODIUM
Category
Other
Salt Form
Sodium
Drug Count
3
Variant Count
148
Last Verified
February 17, 2026
RxCUI
855288, 855292, 855296, 855300, 855302, 855306, 855312, 855316, 855318, 855322, 855324, 855328, 855332, 855336, 855338, 855342, 855344, 855348
UNII
6153CWM0CL
About Warfarin
Warfarin is a potent Vitamin K antagonist (VKA) anticoagulant used to prevent and treat thromboembolic disorders. It requires precise dosing and regular INR monitoring to manage the risk of significant bleeding.
Detailed information about Warfarin
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Warfarin.
The mechanism of action for warfarin is complex and occurs at the molecular level within the liver. To understand how warfarin works, one must understand the role of Vitamin K. Vitamin K is a necessary cofactor for the post-translational carboxylation of glutamate residues on several critical coagulation factors, specifically Factors II (prothrombin), VII, IX, and X, as well as the anticoagulant proteins C and S. This carboxylation process allows these proteins to bind to phospholipid surfaces, a step required for the clotting cascade to proceed. Warfarin works by inhibiting the enzyme Vitamin K epoxide reductase (VKORC1). By blocking this enzyme, warfarin prevents the conversion of oxidized Vitamin K back into its active, reduced form. As the supply of active Vitamin K diminishes, the liver begins to produce clotting factors that are biologically inactive because they lack the necessary carboxylation. It is important to note that warfarin does not have a direct effect on an established thrombus (clot) nor does it reverse ischemic tissue damage; rather, it prevents the extension of existing clots and the formation of new ones. Because the existing, fully functional clotting factors already in the bloodstream must be naturally depleted (Factor II has a half-life of about 60-72 hours), the full clinical effect of warfarin is usually delayed for 3 to 5 days after starting therapy.
Understanding the pharmacokinetics of warfarin is essential for managing its narrow therapeutic index (the small window between a safe dose and a toxic dose).
Warfarin is FDA-approved for several critical indications related to the prevention and treatment of thromboembolic events. Healthcare providers typically use it for:
Off-label uses may include certain hypercoagulable states (conditions where the blood clots too easily), such as antiphospholipid syndrome, though your doctor will weigh the risks and benefits for these specific scenarios.
Warfarin is most commonly available as a sodium salt in oral tablet form. In the United States, these tablets are color-coded by strength to help prevent dosing errors. Common strengths include:
Warfarin is also available as a lyophilized powder for injection, though this is reserved for hospital settings where oral administration is not feasible.
> Important: Only your healthcare provider can determine if Warfarin is right for your specific condition. Regular blood tests (PT/INR) are mandatory to ensure the medication is working safely.
Dosage for warfarin is highly individualized and must be adjusted based on the patient’s Prothrombin Time (PT) and International Normalized Ratio (INR). There is no "standard" dose that fits all patients.
Warfarin is used in children, but it is not FDA-approved for specific pediatric indications in the same way as adults. Pediatric dosing is complex and must be managed by a specialist (such as a pediatric hematologist). Dosing is usually based on weight (mg/kg) and requires very frequent INR monitoring, as children’s diets and metabolic rates change rapidly. Infants often require higher doses per kilogram than older children to achieve a therapeutic INR.
Warfarin does not typically require dose adjustments based solely on kidney function, as it is primarily metabolized by the liver. However, patients with severe renal impairment may have an increased risk of bleeding and may require more frequent monitoring.
Patients with liver disease may be more sensitive to warfarin because the liver produces clotting factors. Hepatic impairment can lead to an exaggerated response to warfarin, necessitating lower doses and very close supervision by a healthcare professional.
Patients over the age of 65 often require lower maintenance doses of warfarin. This increased sensitivity may be due to changes in body composition, reduced liver metabolism, or the presence of other medical conditions. Elderly patients are also at a higher risk for falls, which increases the danger of internal bleeding.
If you miss a dose, take it as soon as you remember on the same day. If it is almost time for your next dose the following day, skip the missed dose and return to your regular schedule. Never take two doses at once to make up for a missed one. Record the missed dose and inform your healthcare provider at your next INR check.
An overdose of warfarin can lead to life-threatening bleeding. Signs of overdose include:
In the event of an overdose, emergency medical attention is required. The antidote for warfarin is Vitamin K1 (phytonadione), which can be administered orally or intravenously to restore clotting factor production. In severe cases, fresh frozen plasma (FFP) or prothrombin complex concentrates (PCC) may be used to provide immediate clotting factors.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking this medication without medical guidance, as doing so increases your risk of a dangerous blood clot.
Because warfarin is designed to slow down the blood's ability to clot, the most common side effects involve minor bleeding and bruising.
> Warning: Stop taking Warfarin and call your doctor immediately or seek emergency care if you experience any of the following serious symptoms.
Warfarin carries a prominent FDA Black Box Warning regarding the risk of bleeding. The warning states that warfarin can cause major or fatal bleeding. Bleeding is more likely to occur during the starting period and with higher doses (resulting in a higher INR). Risk factors for bleeding include high intensity of anticoagulation (INR >4.0), age 65 or older, history of highly variable INRs, history of gastrointestinal bleeding, hypertension, cerebrovascular disease, serious heart disease, anemia, cancer, trauma, renal insufficiency, concomitant drugs, and long duration of warfarin therapy. Regular monitoring of INR should be performed on all treated patients.
Report any unusual symptoms, especially signs of bleeding or skin changes, to your healthcare provider immediately. Even a minor fall should be reported, as it could cause internal bleeding that is not immediately visible.
Warfarin is a high-alert medication, meaning it has a high risk of causing significant patient harm when used incorrectly. The most critical safety point is the maintenance of the International Normalized Ratio (INR) within the specific target range set by your doctor. If the INR is too low, you are at risk for blood clots; if it is too high, you are at risk for life-threatening bleeding. You must never skip a scheduled blood test. Additionally, you must inform all healthcare providers, including dentists and pharmacists, that you are taking warfarin before any procedure or when starting a new medication.
Regular laboratory monitoring is the only way to ensure warfarin safety.
Warfarin itself does not usually cause drowsiness or impairment of motor skills. However, patients should be aware that any accident while driving that results in injury could lead to much more severe bleeding than normal. If you experience dizziness or confusion (which could be signs of a brain bleed), do not drive and seek medical help immediately.
Alcohol consumption should be strictly limited and discussed with your doctor. Acute alcohol consumption (binge drinking) can inhibit the metabolism of warfarin and increase your INR, raising the risk of bleeding. Conversely, chronic heavy alcohol use can induce liver enzymes and decrease the effectiveness of warfarin. It is best to avoid alcohol or keep intake consistent and very moderate.
Do not stop taking warfarin unless instructed by your doctor. Stopping suddenly can significantly increase your risk of a stroke or blood clot. When it is time to stop, your doctor may simply have you stop the medication, as its effects naturally wear off over several days. In some cases, you may be transitioned to a different type of blood thinner.
> Important: Discuss all your medical conditions, especially any history of bleeding disorders, high blood pressure, or recent surgeries, with your healthcare provider before starting Warfarin.
Certain medications should never be used with warfarin because the risk of life-threatening bleeding is too high. These include:
Many drugs interact with warfarin by affecting the CYP450 enzymes in the liver or by displacing warfarin from albumin.
Warfarin primarily affects the PT/INR test. However, it can also interfere with the results of tests for Factor VII, IX, and X levels, and may affect the interpretation of certain protein C and protein S assays. Always tell the lab technician you are on warfarin.
For each major interaction, the mechanism usually involves either the inhibition of the CYP2C9 enzyme (increasing warfarin levels) or a pharmacodynamic effect where the second drug also thins the blood. The clinical consequence is almost always an increased risk of bleeding or a failure to prevent clots. Management strategies involve more frequent INR monitoring and preemptive dose adjustments.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Even over-the-counter vitamins can change how warfarin works.
There are several conditions where the risk of using warfarin is so high that it must never be used:
In these cases, a doctor must perform a careful risk-benefit analysis:
While warfarin is chemically distinct, patients who have had a severe allergic reaction to other coumarin-type anticoagulants (though these are rarely used today) should avoid warfarin. There is no known cross-sensitivity with heparin or the newer DOACs (like Eliquis or Xarelto).
> Important: Your healthcare provider will evaluate your complete medical history, including any history of falls or stomach ulcers, before prescribing Warfarin.
Warfarin is generally contraindicated in pregnancy (formerly FDA Category X). Exposure during the first trimester, especially between weeks 6 and 9, can lead to fetal warfarin syndrome, characterized by skeletal malformations, stunted growth, and cognitive impairment. Use in the third trimester can lead to severe fetal or neonatal hemorrhage. Women of childbearing age must use effective contraception while taking warfarin. If you become pregnant, contact your doctor immediately; they will likely switch you to an injectable anticoagulant like heparin that does not cross the placenta.
Warfarin is generally considered safe for use during breastfeeding. Because it is highly protein-bound, very little of the drug passes into breast milk. Limited studies have shown that the INR of breastfed infants remains unaffected when the mother is on therapeutic doses of warfarin. However, as a precaution, the infant should be monitored for any unusual bruising or bleeding.
Warfarin is used in children for the treatment and prevention of blood clots, often following heart surgery or for certain genetic clotting disorders. It is not FDA-approved for specific pediatric use, so its use is considered "off-label." Dosing is highly variable and requires specialized care. Children often have a more difficult time maintaining a stable INR due to frequent dietary changes, illnesses, and the introduction of new medications.
Patients over age 65 are at a significantly higher risk for both thromboembolic events and bleeding complications. Clinical data shows that elderly patients often require lower doses of warfarin to achieve a therapeutic INR. This population is also more likely to be taking multiple other medications (polypharmacy), increasing the risk of drug interactions. There is also a heightened concern regarding falls and subsequent intracranial hemorrhage.
While the kidneys do not play a primary role in clearing warfarin itself, renal impairment affects the overall safety profile. Patients with a GFR < 30 mL/min may have altered platelet function and a higher risk of vascular calcification (calciphylaxis). No specific dose adjustment is required based on GFR, but more frequent monitoring is recommended. Warfarin is not removed by hemodialysis.
Liver dysfunction (Child-Pugh Class B or C) can significantly increase the response to warfarin. The liver is responsible for synthesizing clotting factors and metabolizing the drug. In hepatic impairment, factor production is already low, and drug clearance is reduced, leading to a much higher risk of over-anticoagulation. Warfarin should be used with extreme caution in these patients.
> Important: Special populations, particularly pregnant women and the elderly, require individualized medical assessment and more frequent monitoring to ensure safety.
Warfarin is a competitive inhibitor of the Vitamin K epoxide reductase complex (VKORC1). This enzyme is responsible for converting Vitamin K epoxide (the inactive form) back into Vitamin K quinone (the active form). Active Vitamin K is a necessary cofactor for the enzyme gamma-glutamyl carboxylase, which adds a carboxyl group to the glutamate residues of clotting factors II, VII, IX, and X, as well as anticoagulant proteins C and S. Without this carboxylation, these factors cannot bind calcium or attach to the phospholipid membranes of platelets, rendering them biologically inactive. By depleting the pool of active Vitamin K, warfarin effectively shuts down the production of functional clotting factors.
The pharmacodynamic effect of warfarin is measured by the Prothrombin Time (PT), which is converted to the International Normalized Ratio (INR). The onset of action is delayed (36-72 hours) because it depends on the natural decay of existing clotting factors. Factor VII has the shortest half-life (6 hours), while Factor II (prothrombin) has the longest (60-72 hours). This is why a patient may have an elevated INR quickly (due to Factor VII depletion) but not be fully protected from clots for several days (until Factor II is depleted).
| Parameter | Value |
|---|---|
| Bioavailability | >90% |
| Protein Binding | 99% (Albumin) |
| Half-life | 20 to 60 hours (Mean: 40 hours) |
| Tmax | 1 to 9 hours |
| Metabolism | Hepatic (CYP2C9, CYP1A2, CYP3A4) |
| Excretion | Renal (92% as inactive metabolites) |
Warfarin sodium is a white, odorless, crystalline powder. Its molecular formula is C19H15NaO4, and it has a molecular weight of 330.31 g/mol. It is very soluble in water and ethanol. Chemically, it is a racemic mixture of the R- and S-enantiomers of 3-(alpha-acetonylbenzyl)-4-hydroxycoumarin.
Warfarin is classified as a Vitamin K Antagonist (VKA) and is a derivative of coumarin. It is the most widely used oral anticoagulant in its class. Related medications include acenocoumarol and phenprocoumon, though these are more common in Europe than in the United States.
Medications containing this ingredient
Common questions about Warfarin
Warfarin is primarily used to prevent and treat blood clots that can lead to serious health issues like strokes, heart attacks, or pulmonary embolisms. Healthcare providers often prescribe it for patients with atrial fibrillation, those who have had heart valve replacements, or individuals with a history of deep vein thrombosis (DVT). It works by slowing down the body's process of making clots by interfering with Vitamin K. Because it is so effective at thinning the blood, it is a vital medication for those at high risk of thromboembolic events. However, its use requires careful medical supervision and regular blood testing to ensure it is working safely and effectively.
The most common side effects of warfarin are related to its intended effect of thinning the blood, which often results in easier bruising and minor bleeding. Patients frequently report that small cuts take longer to stop bleeding or that they experience occasional nosebleeds or bleeding gums when brushing their teeth. Some individuals may also experience mild stomach upset, a feeling of being cold, or thinning hair. While these are common, they should still be discussed with a healthcare provider. It is important to distinguish these from serious bleeding, such as blood in the stool or urine, which requires immediate medical attention. Always monitor your body for any unusual changes while taking this medication.
Alcohol consumption should be strictly limited and discussed with your doctor while taking warfarin. Acute alcohol use, such as binge drinking, can interfere with how your liver breaks down the medication, potentially leading to dangerously high levels of warfarin in your blood and an increased risk of bleeding. On the other hand, chronic heavy drinking can make the medication less effective, increasing your risk of forming a blood clot. Most healthcare providers recommend avoiding alcohol or limiting it to no more than one or two drinks occasionally. Consistency is the most important factor, as sudden changes in your habits can cause your INR levels to fluctuate. Always be honest with your healthcare team about your alcohol intake.
Warfarin is generally not considered safe during pregnancy and is known to cause significant birth defects, a condition called fetal warfarin syndrome. It can cross the placenta and interfere with the development of the fetus's bones and central nervous system, especially during the first trimester. It also poses a high risk of fatal bleeding for the fetus. For these reasons, doctors typically switch pregnant patients or those planning to become pregnant to alternative anticoagulants like heparin, which do not cross the placenta. If you are of childbearing age, you should use effective birth control while on warfarin. If you suspect you are pregnant, you must notify your healthcare provider immediately to change your treatment plan.
Warfarin does not work immediately; it typically takes 3 to 5 days for the full anticoagulant effect to be reached. This delay occurs because warfarin only prevents the production of new clotting factors and does not affect the factors already circulating in your blood. Those existing factors must be naturally used up by your body before the blood is sufficiently thinned. During this initial period, your doctor may "bridge" your treatment by giving you a fast-acting injectable anticoagulant like heparin or enoxaparin. Regular blood tests (INR) will be used to determine exactly when the warfarin has reached its therapeutic level. Patience and strict adherence to your doctor's instructions are essential during this starting phase.
You should never stop taking warfarin suddenly unless your doctor specifically instructs you to do so. Stopping the medication abruptly can cause your blood's clotting ability to return to its previous state, significantly increasing your risk of a life-threatening blood clot, stroke, or heart attack. If you need to stop warfarin for a surgery or procedure, your doctor will provide a specific schedule for tapering off or switching to a different medication temporarily. If you are experiencing side effects, discuss them with your healthcare provider rather than stopping the drug on your own. Your safety depends on maintaining a consistent level of anticoagulation as directed by your medical team.
If you miss a dose of warfarin, take it as soon as you remember on the same day. However, if you do not realize you missed the dose until the next day, skip the missed dose entirely and take your next scheduled dose at the usual time. You should never take two doses at once to make up for a missed one, as this can dangerously increase your risk of bleeding. It is helpful to keep a log of your doses and any missed ones to share with your doctor during your next INR check. If you miss doses frequently, talk to your pharmacist about tools like pill organizers or phone alarms to help you stay on track. Consistency is vital for keeping your INR in the safe range.
Weight gain is not a typical or well-documented side effect of warfarin itself. If you notice a sudden or significant increase in weight while taking this medication, it is more likely related to other factors, such as changes in diet, activity levels, or other underlying medical conditions like heart failure. In some cases, swelling (edema) can cause weight gain, which should be evaluated by a doctor. It is important to maintain a stable diet and exercise routine while on warfarin, as major lifestyle changes can affect how the drug is metabolized. If you have concerns about your weight, discuss them with your healthcare provider to identify the root cause. Do not attempt a restrictive new diet without medical consultation.
Warfarin has a very long list of interactions with other medications, including prescription drugs, over-the-counter medicines, and herbal supplements. Many common drugs, such as certain antibiotics, antidepressants, and anti-inflammatory medications (like ibuprofen), can either increase or decrease the effect of warfarin. This can lead to either a higher risk of bleeding or a higher risk of blood clots. Because of this, it is crucial to inform your doctor and pharmacist about every single product you are taking. You should also check with your healthcare provider before starting any new medication, even something as simple as a cold remedy or a vitamin. Close monitoring of your INR is usually required whenever a new medication is added or removed.
Yes, warfarin is available as a generic medication and is generally very affordable. The brand name version most people recognize is Coumadin, though the generic version is used by the vast majority of patients. While generic medications are required to be bioequivalent to the brand name, some doctors recommend staying with the same manufacturer once a stable INR is achieved, as minor variations between manufacturers could theoretically affect your levels. If your pharmacy changes the manufacturer of your generic warfarin, your doctor may want to check your INR a bit sooner than usual. Regardless of whether you take the brand or generic, the most important factor is taking the exact dose prescribed at the same time every day.